Navco Pharmaceuticals Inc. Stock Toronto S.E.

Equities

NAV

CA05587L1031

Personal Products

End-of-day quote Toronto S.E. 06:00:00 2024-01-25 pm EST 5-day change 1st Jan Change
0.035 CAD -12.50% Intraday chart for Navco Pharmaceuticals Inc. -12.50% +40.00%
Sales 2022 58.73K 42.93K Sales 2023 - Capitalization 1.21M 885K
Net income 2022 - 0 Net income 2023 -2M -1.46M EV / Sales 2022 * -
Net Debt 2022 896K 655K Net Debt 2023 370K 270K EV / Sales 2023 -
P/E ratio 2022 *
-
P/E ratio 2023
-0.42 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
Navco Pharmaceuticals Inc. is a Canada-based company. The Company is engaged in developing and commercializing products to protect against viruses, bacteria, and infectious diseases. It manufactures and researches nanotechnology products and materials using Computerized Nano-meter Algorithms (CNA). The Company's pipeline of applications is tailored to defend against microorganisms such as viruses, bacteria, fungi, and genetic manipulation tools such as clustered regularly interspaced short palindromic repeats (CRISPR). Its target markets include human health and personal skin care, household and institutional products and veterinary health. It offers multiple main product lines, namely, an aerosol spray, hand sanitizer, hand cream, and nano BioGuard-Silver. It also offers sublingual strips (the MunoStrips) infused with immune-boosting compounds to help maintain immune function and help support the body’s metabolism.
More about the company